Interview with Dr David Healy, 13 February 2013

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

StandardStandard

Interview with Dr David Healy, 13 February 2013. / Peters, K.R.; Katz, S.; Healy, D.
Yn: Dementia, Cyfrol 14, Rhif 3, 01.05.2015, t. 361-369.

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

HarvardHarvard

Peters, KR, Katz, S & Healy, D 2015, 'Interview with Dr David Healy, 13 February 2013', Dementia, cyfrol. 14, rhif 3, tt. 361-369. https://doi.org/10.1177/1471301214562139

APA

Peters, K. R., Katz, S., & Healy, D. (2015). Interview with Dr David Healy, 13 February 2013. Dementia, 14(3), 361-369. https://doi.org/10.1177/1471301214562139

CBE

Peters KR, Katz S, Healy D. 2015. Interview with Dr David Healy, 13 February 2013. Dementia. 14(3):361-369. https://doi.org/10.1177/1471301214562139

MLA

Peters, K.R., S. Katz a D. Healy. "Interview with Dr David Healy, 13 February 2013". Dementia. 2015, 14(3). 361-369. https://doi.org/10.1177/1471301214562139

VancouverVancouver

Peters KR, Katz S, Healy D. Interview with Dr David Healy, 13 February 2013. Dementia. 2015 Mai 1;14(3):361-369. doi: 10.1177/1471301214562139

Author

Peters, K.R. ; Katz, S. ; Healy, D. / Interview with Dr David Healy, 13 February 2013. Yn: Dementia. 2015 ; Cyfrol 14, Rhif 3. tt. 361-369.

RIS

TY - JOUR

T1 - Interview with Dr David Healy, 13 February 2013

AU - Peters, K.R.

AU - Katz, S.

AU - Healy, D.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Dr David Healy is an internationally renowned and respected psychiatrist, psychopharmacologist, scientist and author. A professor of Psychiatry at Bangor University in Wales, he studied medicine in Dublin and at Cambridge University. He is a former Secretary of the British Association for Psychopharmacology and has authored more than 150 peer-reviewed articles, 200 other pieces and 20 books. Dr Healy’s main areas of research are clinical trials in psychopharmacology, the history of psychopharmacology, and the impact of both trials and psychotropic drugs on our culture. He has been involved as an expert witness in homicide and suicide trials involving psychotropic drugs, and in bringing problems with these drugs to the attention of American and British regulators, as well raising awareness of how pharmaceutical companies sell drugs by marketing diseases and co-opting academic opinion-leaders, ghost-writing their articles. Dr Healy is also a founder and Chief Executive Officer of Data Based Medicine Limited, which operates through its popular global website www.RxISK.org, dedicated to making medicines safer through online direct patient reporting of drug effect

AB - Dr David Healy is an internationally renowned and respected psychiatrist, psychopharmacologist, scientist and author. A professor of Psychiatry at Bangor University in Wales, he studied medicine in Dublin and at Cambridge University. He is a former Secretary of the British Association for Psychopharmacology and has authored more than 150 peer-reviewed articles, 200 other pieces and 20 books. Dr Healy’s main areas of research are clinical trials in psychopharmacology, the history of psychopharmacology, and the impact of both trials and psychotropic drugs on our culture. He has been involved as an expert witness in homicide and suicide trials involving psychotropic drugs, and in bringing problems with these drugs to the attention of American and British regulators, as well raising awareness of how pharmaceutical companies sell drugs by marketing diseases and co-opting academic opinion-leaders, ghost-writing their articles. Dr Healy is also a founder and Chief Executive Officer of Data Based Medicine Limited, which operates through its popular global website www.RxISK.org, dedicated to making medicines safer through online direct patient reporting of drug effect

U2 - 10.1177/1471301214562139

DO - 10.1177/1471301214562139

M3 - Article

VL - 14

SP - 361

EP - 369

JO - Dementia

JF - Dementia

SN - 1471-3012

IS - 3

ER -